Stay updated on VX-152 Combo Safety in CF Adults Clinical Trial
Sign up to get notified when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.

Latest updates to the VX-152 Combo Safety in CF Adults Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference4%

- Check31 days agoChange DetectedAdded a new version label (v3.1.0) and removed several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with a previous revision (v3.0.2).SummaryDifference0.4%

- Check45 days agoChange DetectedUpdated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element; no other substantive content changes.SummaryDifference0.2%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check60 days agoChange DetectedThe web page has undergone significant updates, including the addition of a new facility name and location in St. Louis, Missouri, along with new resources related to cystic fibrosis and drug safety. However, several previous location details and specific drug information have been removed.SummaryDifference3%

- Check74 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to VX-152 Combo Safety in CF Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX-152 Combo Safety in CF Adults Clinical Trial page.